Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes
- PMID: 34599904
- PMCID: PMC8480960
- DOI: 10.1016/S2213-2600(21)00413-6
Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes
Conflict of interest statement
EL reports personal fees from Sanofi Pasteur for participation in a global influenza vaccination advisory board, outside the area of work commented on here. BAL and KN were supported by NIH/NIAID R01 AI143875 and NIH/NIGMS R01 GM124280.
Comment on
-
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.Lancet Respir Med. 2021 Dec;9(12):1439-1449. doi: 10.1016/S2213-2600(21)00380-5. Epub 2021 Sep 29. Lancet Respir Med. 2021. PMID: 34599903 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical